The Scientist

» p53

Most Recent

image: Explaining Elephants’ Cancer Resistance

Explaining Elephants’ Cancer Resistance

By | October 13, 2015

Two studies reveal that the giant mammals have dozens of extra copies of a cancer-preventing gene.

0 Comments

image: Book Excerpt from <em>p53</em>

Book Excerpt from p53

By | April 1, 2015

In Chapter 12, "Of Mice and Men," author Sue Armstrong recounts the point at which researchers moved from working with p53 in tissue culture to studying the gene in animal models.

0 Comments

image: Setbacks and Great Leaps

Setbacks and Great Leaps

By | April 1, 2015

The tale of p53, a widely studied tumor suppressor gene, illustrates the inventiveness of researchers who turn mishaps into discoveries.

1 Comment

image: An Obesity-Cancer Link?

An Obesity-Cancer Link?

By | November 22, 2011

Why obese individual are more likely to get cancer could be partly explained by a gene that activates both pathways.

3 Comments

image: MicroRNAs Prevent Cell Reprogramming

MicroRNAs Prevent Cell Reprogramming

By | October 24, 2011

A group of microRNAs can inhibit the formation of induced pluripotent stem cells, and may provide a target for more efficient reprogramming of somatic cells.

0 Comments

image: The Axis of Aging

The Axis of Aging

By | June 14, 2011

Editor's choice in developmental biology

0 Comments

image: Top 7 in molecular biology

Top 7 in molecular biology

By | June 14, 2011

A snapshot of the most highly ranked articles in molecular biology, from Faculty of 1000.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech